Florida drivers are facing another week of rising fuel costs, with the state average increasing for a second consecutive week. While prices remain below the national average, the upward trend is squeezing household budgets.
Fabrinet (FN) reported robust fiscal Q2 2026 results, beating estimates with revenue of $1.13B and issuing upbeat guidance. However, the stock fell sharply as investors weighed aggressive expansion plans against high expectations and execution risks.
A petition by Sempra's utilities to alter hydrogen blending mandates puts a spotlight on the practical challenges and financial implications of integrating the fuel into California's existing gas infrastructure, as the state balances climate goals with grid reliability.
Klarna has joined Google's Universal Commerce Protocol, deepening their partnership to standardize AI-driven shopping and payments. The move aims to streamline cross-platform checkouts but unfolds as investors question the valuation and tangible impact of AI in commerce.
Hospital leaders across Connecticut are mounting a fierce defense against a proposed increase in the state's provider tax, arguing that chronic Medicaid underpayments have pushed the healthcare system to a breaking point where new taxes could jeopardize care for vulnerable communities.
UnitedHealth Group, already navigating a turbulent period, confronts a new challenge as federal regulators propose a near-flat payment increase for Medicare Advantage plans in 2027, threatening a key revenue driver for the healthcare giant.
Drivers across the Midwest saw modest relief at the pump last week, with regional averages falling amid a broader national trend of stabilizing fuel costs.
Amidst a cautious market environment shaped by RBA rate hikes and global tech volatility, a closer look reveals resilient opportunities. We examine three ASX-listed penny stocks—from biotech to mining—that are navigating the headwinds with distinct strategies and potential.
At a major Wall Street Journal conference in Palm Beach, financial leaders from Blackstone, Citi, and Lazard grappled with the immediate market fallout and long-term implications of an AI startup's latest move, revealing a stark divide between panic and opportunity.
Commonwealth Financial Network has reached a settlement with the SEC, bringing to a close a five-year legal battle over allegations the firm failed to disclose conflicts in mutual fund share class recommendations.
Even as Warren Buffett steps back from day-to-day leadership at Berkshire Hathaway, his value-investing principles remain a powerful guide for building long-term wealth. We analyze three holdings from the Berkshire portfolio that embody his approach for investors seeking stability and growth in their retirement years.
The crypto asset manager has launched seven model portfolios, leveraging both proprietary and third-party ETFs, to provide financial advisors with structured pathways for client exposure to digital assets.
Horace Mann Educators posted a 6.3% year-over-year revenue increase to $434.8 million in Q4 2025, though it slightly missed top-line estimates. Earnings per share of $1.21 edged past consensus. The insurer's push into new markets and partnerships fuels growth, but management warns of returning catastrophe costs and inflationary pressures ahead.
The aviation industry faces a turbulent start to 2026 as another airline, Romania's Legend Airlines, officially winds down operations. Its closure follows a series of high-profile shutdowns and bankruptcies globally, highlighting persistent pressures on regional and niche carriers.
Apple's latest quarterly results, fueled by 'staggering' iPhone demand, signal robust growth and resilience against long-standing market concerns.
As Bitcoin struggles to hold the $73,000 level, decentralized prediction platform Polymarket shows traders are betting heavily on a further drop to $65,000 this year, reflecting a stark shift in sentiment from earlier bullish forecasts.
The National Highway Traffic Safety Administration has launched a preliminary investigation into Waymo's self-driving system following an incident where a child was hit near an elementary school. The case raises urgent questions about autonomous vehicle performance in complex, child-dense environments.
Reason's Robby Soave argues the mass release of Jeffrey Epstein-related files has fueled a partisan witch hunt, prioritizing political smears over justice and threatening civil liberties.
Driven by a near-doubling in sales of its key cancer drug Jemperli and sustained growth in its HIV division, GSK reported a 7% rise in annual sales. The results provide a solid foundation for new CEO Luke Miels, who is steering the company toward an accelerated pipeline strategy to navigate looming patent cliffs.
Eli Lilly's blockbuster drugs Mounjaro and Zepbound have propelled it to a commanding lead in the lucrative weight-loss and diabetes market, while rival Novo Nordisk warns of declining sales in 2026, sending its shares tumbling.
